Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of Tulisokibart (MK-7240) in adults with moderate to severe Crohn's disease, and the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Tulisokibart

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Crohn's Disease | Phase 3 | Status: RECRUITING